Krill harvester Aker BioMarine has made a "significant breakthrough," with a new krill-sourced EPA and DHA product that will play into the burgeoning human eye and brain health market.
Lysoveta is a new delivery platform based on LPC-bound EPA and DHA and is the firstcommercially available LPC product in the market, except for high cost and small amounts of synthetically produced material for research purposes.
